Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: wayne fishback who wrote (2907)	11/20/1997 3:14:00 PM
From: margie	Read Replies (1) \| Respond to of 6136

Wayne, Best wishes to your son, and thanks for your posts.. December 1 is World AIDS Day World AIDS Day 1997 Focuses On Children rferl.org Third World Must Not Be Deprived Of The Most Advanced Medical Treatments Against AIDS, UNESCO Director-General Declares eurekalert.org

To: wayne fishback who wrote (2907)	11/20/1997 7:28:00 PM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

What do you do when patients do not tolerate viracept, or it fails?. You change to something else, Cryx is better tolerated than norvir. I have never really liked cryx, most of the pts I have given it to developed renal stones, it is hard to take. But, still it is in the armamentarium. In about 6 months, I predict that Viracept will be #1. By the way, keep the faith. Your son should do well, it sounds like he is being treated well. I have found that when patients are treated agressively, and optimally, they do very well. I have patients that were dying back in 1991, and they are doing well. I only had 3 patients die in 1995, 2in 1996, and 2 this year (out of over 200). You should see my patients, I should look that good. Thank you, JLL JLL